{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T13:35:24Z","timestamp":1767965724505,"version":"3.49.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Advanced Diagnostic Imaging Center Research Fund, Mahidol University Faculty of Medicine Ramathibodi Hospital, Bangkok, Thailand"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Coronary computed tomography angiography (CCTA) enables improved diagnosis of subclinical, coronary artery disease (CAD). This retrospective cohort study investigated the association between different treatment modalities guided by CCTA and the prevention of major adverse cardiovascular events (MACEs) in patients with stable CAD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From 2005 to 2013, a total of 9338 patients, including both asymptomatic individuals with risk factors and symptomatic patients with suspected CAD, who underwent CCTA were analyzed. The patients were categorized into one of three groups based on results of CCTA: obstructive CAD (\u2265\u200950% stenosis in at least one vessel), non-obstructive CAD (1\u201349% stenosis in at least one vessel), and no observed CAD (0% stenosis). They were subsequently followed up to assess the treatment they received and the occurrence of MACEs (cardiovascular death, non-fatal myocardial infarction, non-fatal stroke, or late revascularization).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>During an average follow-up period of 9.9\u2009\u00b1\u20092.4 years, patients with obstructive CAD had the highest incidence of MACEs (19.8%), followed by those with non-obstructive CAD and no coronary artery stenosis (10.3 and 5.5%, respectively). After adjusting for confounding variables, it was found that patients treated with statins alone were the least likely to develop MACEs in all three groups, compared to those receiving no treatment, with hazard ratios (95% CI) of 0.43 (0.32, 0.58), 0.47 (0.34, 0.64), and 0.46 (0.31, 0.69), respectively. In patients with obstructive CAD, treatment with a combination of statin and aspirin, or early revascularization was associated with a lower likelihood of experiencing MACEs compared to no treatment with hazard ratios of 0.43 (0.33, 0.58) and 0.64 (0.43, 0.97), respectively.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>CCTA offers useful guidance for the treatment of patients with stable CAD and shows potential for prevention of CV events. However, the full validation of a given strategy utilizing CCTA will require a prospective longitudinal study, utilizing a randomized clinical trial design.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00392-023-02313-1","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T10:01:57Z","timestamp":1696413717000},"page":"433-445","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Impact of coronary CT angiography in selection of treatment modalities and subsequent cardiovascular events in Thai patients with stable CAD"],"prefix":"10.1007","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1457-350X","authenticated-orcid":false,"given":"Thosaphol","family":"Limpijankit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sutipong","family":"Jongjirasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krissada","family":"Meemook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nattawut","family":"Unwanatham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sasivimol","family":"Rattanasiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ammarin","family":"Thakkinstian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiraporn","family":"Laothamatas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"key":"2313_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1161\/CIRCOUTCOMES.118.005375","volume":"12","author":"AN Nowbar","year":"2019","unstructured":"Nowbar AN, Gitto M, Howard JP, Francis DP, Al-Lamee R (2019) Mortality from ischemic heart disease. Analysis of data from the World Health Organization and coronary artery disease risk factors from NCD risk factor collaboration. Circ Cardiovasc Qual Outcomes 12:1\u201311. https:\/\/doi.org\/10.1161\/CIRCOUTCOMES.118.005375","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"2313_CR2","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.jcmg.2017.01.009","volume":"10","author":"A Rozanski","year":"2017","unstructured":"Rozanski A, Muhlestein JB, Berman DS (2017) Primary prevention of CVD: the role of imaging trials. JACC Cardiovasc Imaging 10:304\u2013317. https:\/\/doi.org\/10.1016\/j.jcmg.2017.01.009","journal-title":"JACC Cardiovasc Imaging"},{"key":"2313_CR3","doi-asserted-by":"publisher","first-page":"20140594","DOI":"10.1259\/bjr.20140594","volume":"88","author":"S Divakaran","year":"2015","unstructured":"Divakaran S, Cheezum MK, Hulten EA, Bittencourt MS, Silverman MG, Nasir K, Blankstein R (2015) Use of cardiac CT and calcium scoring for detecting coronary plaque: implications on prognosis and patient management. Br J Radiol 88:20140594. https:\/\/doi.org\/10.1259\/bjr.20140594","journal-title":"Br J Radiol"},{"key":"2313_CR4","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jacc.2008.02.086","volume":"52","author":"EK Choi","year":"2008","unstructured":"Choi EK, Il CS, Rivera JJ, Nasir K, Chang SA, Chun EJ, Kim HK, Choi DJ, Blumenthal RS, Chang HJ (2008) Coronary computed tomography angiography as a screening tool for the detection of occult coronary artery disease in asymptomatic individuals. J Am Coll Cardiol 52:357\u2013365. https:\/\/doi.org\/10.1016\/j.jacc.2008.02.086","journal-title":"J Am Coll Cardiol"},{"key":"2313_CR5","doi-asserted-by":"publisher","first-page":"2383","DOI":"10.1016\/S0140-6736(15)60291-4","volume":"385","author":"The SCOT-HEART investigators","year":"2015","unstructured":"The SCOT-HEART investigators (2015) CT coronary angiography in patients with suspected angina due to coronary heart disease (SCOT-HEART): an open-label, parallel-group, multicentre trial. Lancet 385:2383\u20132391. https:\/\/doi.org\/10.1016\/S0140-6736(15)60291-4","journal-title":"Lancet"},{"key":"2313_CR6","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.jacc.2016.02.026","volume":"67","author":"MC Williams","year":"2016","unstructured":"Williams MC, Hunter A, Shah ASV et al (2016) Use of coronary computed tomographic angiography to guide management of patients with coronary disease. J Am Coll Cardiol 67:1759\u20131768. https:\/\/doi.org\/10.1016\/j.jacc.2016.02.026","journal-title":"J Am Coll Cardiol"},{"key":"2313_CR7","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1056\/NEJMoa1805971","volume":"379","author":"SCOT-HEART Investigators","year":"2018","unstructured":"Investigators SCOT-HEART, Newby DE, Adamson PD, Berry C et al (2018) Coronary CT angiography and 5-year risk of myocardial infarction. N Engl J Med 379:924\u2013933. https:\/\/doi.org\/10.1056\/NEJMoa1805971","journal-title":"N Engl J Med"},{"key":"2313_CR8","doi-asserted-by":"publisher","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","volume":"135","author":"U Hoffmann","year":"2017","unstructured":"Hoffmann U, Ferencik M, Udelson JE et al (2017) Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain). Circulation 135:2320\u20132332. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.116.024360","journal-title":"Circulation"},{"key":"2313_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","volume":"41","author":"J Knuuti","year":"2020","unstructured":"Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407\u2013477. https:\/\/doi.org\/10.1093\/eurheartj\/ehz425","journal-title":"Eur Heart J"},{"key":"2313_CR10","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.jacc.2020.06.078","volume":"76","author":"M Poon","year":"2020","unstructured":"Poon M, Lesser JR, Biga C et al (2020) Current evidence and recommendations for coronary CTA first in evaluation of stable coronary artery disease. J Am Coll Cardiol 76:1358\u20131362. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.078","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"2313_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s12410-017-9412-6","volume":"10","author":"AJ Moss","year":"2017","unstructured":"Moss AJ, Williams MC, Newby DE, Nicol ED (2017) The updated NICE guidelines: cardiac CT as the first-line test for coronary artery disease. Curr Cardiovasc Imaging Rep 10(5):15. https:\/\/doi.org\/10.1007\/s12410-017-9412-6","journal-title":"Curr Cardiovasc Imaging Rep"},{"key":"2313_CR12","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1161\/CIRCULATIONAHA.111.081380","volume":"126","author":"I Cho","year":"2012","unstructured":"Cho I, Chang HJ, Sung JM et al (2012) Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM registry (Coronary CT angiography evaluation for clinical outcomes: an international multicenter registry. Circulation 126:304\u2013313. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.111.081380","journal-title":"Circulation"},{"key":"2313_CR13","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/978-1-60327-237-7_58","volume-title":"CT of the heart. Contemporary medical imaging","author":"FG Meinel","year":"2019","unstructured":"Meinel FG, Renker M (2019) Coronary CT angiography for screening, risk stratification, and management of asymptomatic patients: state of the evidence. In: Schoepf U (ed) CT of the heart. Contemporary medical imaging. Humana, Totowa, pp 739\u2013745. https:\/\/doi.org\/10.1007\/978-1-60327-237-7_58"},{"issue":"25","key":"2313_CR14","doi-asserted-by":"publisher","first-page":"e1082","DOI":"10.1161\/CIR.0000000000000625","volume":"139","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL et al (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines. Circulation 139(25):e1082\u2013e1143. https:\/\/doi.org\/10.1161\/CIR.0000000000000625","journal-title":"Circulation"},{"key":"2313_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"F Mach","year":"2020","unstructured":"Mach F, Baigent C, Catapano AL et al (2020) 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 41:111\u2013188. https:\/\/doi.org\/10.1093\/eurheartj\/ehz455","journal-title":"Eur Heart J"},{"key":"2313_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1161\/CIRCIMAGING.113.000470","volume":"7","author":"C Andersson","year":"2014","unstructured":"Andersson C, Vasan RS (2014) Is there a role for coronary artery calcium scoring for management of asymptomatic patients at risk for coronary artery disease? Circ Cardiovasc Imaging 7:390\u2013397. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000470","journal-title":"Circ Cardiovasc Imaging"},{"key":"2313_CR17","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1161\/circulationaha.119.045010","volume":"141","author":"M Cainzos-Achirica","year":"2020","unstructured":"Cainzos-Achirica M, Miedema MD, McEvoy JW et al (2020) Coronary artery calcium for personalized allocation of aspirin in primary prevention of cardiovascular disease in 2019: the MESA Study (Multi-Ethnic Study of Atherosclerosis). Circulation 141:1541\u20131553. https:\/\/doi.org\/10.1161\/circulationaha.119.045010","journal-title":"Circulation"},{"key":"2313_CR18","first-page":"18","volume":"15","author":"S Pattanaprichakul","year":"2007","unstructured":"Pattanaprichakul S, Jongjirasiri S, Yamwong S (2007) RAMA-EGAT risk score for predicting coronary artery disease evaluated by 64- slice CT angiography. ASEAN Heart J 15:18\u201322","journal-title":"ASEAN Heart J"},{"key":"2313_CR19","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1002\/clc.23735","volume":"44","author":"T Limpijankit","year":"2021","unstructured":"Limpijankit T, Vathesatogkit P, Matchariyakul D, Yingchoncharoen T, Siriyotha S, Thakkinstian A, Sritara P (2021) Cardio-ankle vascular index as a predictor of major adverse cardiovascular events in metabolic syndrome patients. Clin Cardiol 44:1628\u20131635. https:\/\/doi.org\/10.1002\/clc.23735","journal-title":"Clin Cardiol"},{"issue":"6","key":"2313_CR20","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.jjcc.2021.07.011","volume":"78","author":"T Miyoshi","year":"2021","unstructured":"Miyoshi T, Ito H (2021) Arterial stiffness in health and disease: the role of cardio\u2013ankle vascular index. J Cardiol 78(6):493\u2013501. https:\/\/doi.org\/10.1016\/j.jjcc.2021.07.011","journal-title":"J Cardiol"},{"key":"2313_CR21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.5551\/jat.29926","volume":"22","author":"S-L Chung","year":"2015","unstructured":"Chung S-L, Yang C-C, Chen C-C, Hsu Y-C, Lei M-H (2015) Coronary artery calcium score compared with cardio-ankle vascular index in the prediction of cardiovascular events in asymptomatic patients with type 2 diabetes. J Atheroscler Thromb 22:1255\u20131265. https:\/\/doi.org\/10.5551\/jat.29926","journal-title":"J Atheroscler Thromb"},{"key":"2313_CR22","doi-asserted-by":"publisher","first-page":"4391","DOI":"10.1002\/sim.7501","volume":"36","author":"PC Austin","year":"2017","unstructured":"Austin PC, Fine JP (2017) Practical recommendations for reporting Fine-Gray model analyses for competing risk data. Stat Med 36:4391\u20134400. https:\/\/doi.org\/10.1002\/sim.7501","journal-title":"Stat Med"},{"key":"2313_CR23","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","volume":"3","author":"M Ferencik","year":"2018","unstructured":"Ferencik M, Mayrhofer T, Bittner DO et al (2018) Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial. JAMA Cardiol 3:144\u2013152. https:\/\/doi.org\/10.1001\/jamacardio.2017.4973","journal-title":"JAMA Cardiol"},{"key":"2313_CR24","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1016\/j.jacc.2012.05.062","volume":"60","author":"LJ Shaw","year":"2012","unstructured":"Shaw LJ, Hausleiter J, Achenbach S et al (2012) Coronary computed tomographic angiography as a gatekeeper to invasive diagnostic and surgical procedures. J Am Coll Cardiol 60:2103\u20132114. https:\/\/doi.org\/10.1016\/j.jacc.2012.05.062","journal-title":"J Am Coll Cardiol"},{"key":"2313_CR25","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1016\/j.jcmg.2016.05.005","volume":"9","author":"RC Cury","year":"2016","unstructured":"Cury RC, Abbara S, Achenbach S et al (2016) Coronary artery disease\u2014reporting and data system (CAD-RADS). JACC Cardiovasc Imaging 9:1099\u20131113. https:\/\/doi.org\/10.1016\/j.jcmg.2016.05.005","journal-title":"JACC Cardiovasc Imaging"},{"key":"2313_CR26","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.jacc.2013.04.064","volume":"62","author":"M Hadamitzky","year":"2013","unstructured":"Hadamitzky M, Achenbach S, Al-Mallah M et al (2013) Optimized prognostic score for coronary computed tomographic angiography: results from the CONFIRM registry (COronary CT Angiography EvaluatioN for Clinical Outcomes: an InteRnational Multicenter Registry). J Am Coll Cardiol 62:468\u2013476. https:\/\/doi.org\/10.1016\/j.jacc.2013.04.064","journal-title":"J Am Coll Cardiol"},{"key":"2313_CR27","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.jacc.2008.07.027","volume":"52","author":"MP Ostrom","year":"2008","unstructured":"Ostrom MP, Gopal A, Ahmadi N, Nasir K, Yang E, Kakadiaris I, Flores F, Mao SS, Budoff MJ (2008) Mortality incidence and the severity of coronary atherosclerosis assessed by computed tomography angiography. J Am Coll Cardiol 52:1335\u20131343. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.027","journal-title":"J Am Coll Cardiol"},{"key":"2313_CR28","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0003319721999494","volume":"72","author":"D Ko\u0161uta","year":"2021","unstructured":"Ko\u0161uta D, Jug B, Fras Z (2021) Prognostic impact of nonobstructive coronary artery disease detected by coronary computed tomographic angiography. Angiology 72:749\u2013753. https:\/\/doi.org\/10.1177\/0003319721999494","journal-title":"Angiology"},{"key":"2313_CR29","doi-asserted-by":"publisher","first-page":"651","DOI":"10.2217\/14796678.2.6.651","volume":"2","author":"AK Chhatriwalla","year":"2006","unstructured":"Chhatriwalla AK, Nicholls SJ, Nissen SE (2006) The ASTEROID trial: coronary plaque regression with high-dose statin therapy. Future Cardiol 2:651\u2013654. https:\/\/doi.org\/10.2217\/14796678.2.6.651","journal-title":"Future Cardiol"},{"key":"2313_CR30","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.5551\/jat.34660","volume":"23","author":"K Wakabayashi","year":"2016","unstructured":"Wakabayashi K, Nozue T, Yamamoto S et al (2016) Efficacy of statin therapy in inducing coronary plaque regression in patients with low baseline cholesterol levels. J Atheroscler Thromb 23:1055\u20131066. https:\/\/doi.org\/10.5551\/jat.34660","journal-title":"J Atheroscler Thromb"},{"key":"2313_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-87528-w","volume":"11","author":"Y Li","year":"2021","unstructured":"Li Y, Deng S, Liu B et al (2021) The effects of lipid-lowering therapy on coronary plaque regression: a systematic review and meta-analysis. Sci Rep 11:1\u201310. https:\/\/doi.org\/10.1038\/s41598-021-87528-w","journal-title":"Sci Rep"},{"key":"2313_CR32","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.jcmg.2018.04.015","volume":"11","author":"S-E Lee","year":"2018","unstructured":"Lee S-E, Chang H-J, Sung JM et al (2018) Effects of statins on coronary atherosclerotic plaques: the PARADIGM study. JACC Cardiovasc Imaging 11:1475\u20131484. https:\/\/doi.org\/10.1016\/j.jcmg.2018.04.015","journal-title":"JACC Cardiovasc Imaging"},{"key":"2313_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2376","volume":"338","author":"JJ Brugts","year":"2009","unstructured":"Brugts JJ, Yetgin T, Hoeks SE et al (2009) The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials. BMJ 338:b2376. https:\/\/doi.org\/10.1136\/bmj.b2376","journal-title":"BMJ"},{"issue":"12","key":"2313_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0207194","volume":"13","author":"YK Cho","year":"2018","unstructured":"Cho YK, Nam CW, Koo BK et al (2018) Usefulness of baseline statin therapy in non-obstructive coronary artery disease by coronary computed tomographic angiography: from the CONFIRM (COronary CT Angiography EvaluatioN For Clinical Outcomes: an InteRnational Multicenter) study. PLoS ONE 13(12):e0207194. https:\/\/doi.org\/10.1371\/journal.pone.0207194","journal-title":"PLoS ONE"},{"key":"2313_CR35","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1161\/ATVBAHA.114.304351","volume":"35","author":"BJW Chow","year":"2015","unstructured":"Chow BJW, Small G, Yam Y et al (2015) Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease. Arterioscler Thromb Vasc Biol 35:981\u2013989. https:\/\/doi.org\/10.1161\/ATVBAHA.114.304351","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2313_CR36","doi-asserted-by":"publisher","DOI":"10.1148\/ryct.210225","volume":"4","author":"P Indraratna","year":"2022","unstructured":"Indraratna P, Naoum C, Ben Zekry S et al (2022) Aspirin and statin therapy for nonobstructive coronary artery disease: five-year outcomes from the CONFIRM registry. Radiol Cardiothorac Imaging 4:e210225. https:\/\/doi.org\/10.1148\/ryct.210225","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2313_CR37","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.atherosclerosis.2015.01.036","volume":"239","author":"I-C Hwang","year":"2015","unstructured":"Hwang I-C, Jeon J-Y, Kim Y, Kim HM, Yoon YE, Lee S-P, Kim H-K, Sohn D-W, Sung J, Kim Y-J (2015) Statin therapy is associated with lower all-cause mortality in patients with non-obstructive coronary artery disease. Atherosclerosis 239:335\u2013342. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2015.01.036","journal-title":"Atherosclerosis"},{"key":"2313_CR38","doi-asserted-by":"publisher","first-page":"e596","DOI":"10.1161\/CIR.0000000000000678","volume":"140","author":"DK Arnett","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA et al (2019) 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines. Circulation 140:e596\u2013e646. https:\/\/doi.org\/10.1161\/CIR.0000000000000678","journal-title":"Circulation"},{"key":"2313_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1001\/jama.2018.20578","volume":"321","author":"SL Zheng","year":"2019","unstructured":"Zheng SL, Roddick AJ (2019) Association of aspirin use for primary prevention with cardiovascular events and bleeding events: a systematic review and meta-analysis. JAMA 321:277\u2013287. https:\/\/doi.org\/10.1001\/jama.2018.20578","journal-title":"JAMA"},{"key":"2313_CR40","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1093\/eurheartj\/ehy813","volume":"40","author":"AN Mahmoud","year":"2019","unstructured":"Mahmoud AN, Gad MM, Elgendy AY, Elgendy IY, Bavry AA (2019) Efficacy and safety of aspirin for primary prevention of cardiovascular events: a meta-analysis and trial sequential analysis of randomized controlled trials. Eur Heart J 40:607\u2013617. https:\/\/doi.org\/10.1093\/eurheartj\/ehy813","journal-title":"Eur Heart J"},{"key":"2313_CR41","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1056\/nejmoa1804988","volume":"379","author":"L Bowman","year":"2018","unstructured":"Bowman L, Mafham M, Wallendszus K et al (2018) Effects of aspirin for primary prevention in persons with diabetes mellitus. N Engl J of Med 379:1529\u20131539. https:\/\/doi.org\/10.1056\/nejmoa1804988","journal-title":"N Engl J of Med"},{"key":"2313_CR42","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","volume":"392","author":"JM Gaziano","year":"2018","unstructured":"Gaziano JM, Brotons C, Coppolecchia R et al (2018) Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial. Lancet 392:1036\u20131046. https:\/\/doi.org\/10.1016\/S0140-6736(18)31924-X","journal-title":"Lancet"},{"key":"2313_CR43","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/nejmoa1803955","volume":"379","author":"JJ McNeil","year":"2018","unstructured":"McNeil JJ, Wolfe R, Woods RL et al (2018) Effect of aspirin on all-cause mortality in the healthy elderly. N Engl J Med 379:1519\u20131528. https:\/\/doi.org\/10.1056\/nejmoa1803955","journal-title":"N Engl J Med"},{"key":"2313_CR44","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O\u2019Rourke RA, Teo KK et al (2007) Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356:1503\u20131516. https:\/\/doi.org\/10.1056\/NEJMoa070829","journal-title":"N Engl J Med"},{"key":"2313_CR45","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1056\/nejmoa1915922","volume":"382","author":"DJ Maron","year":"2020","unstructured":"Maron DJ, Hochman JS, Reynolds HR et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395\u20131407. https:\/\/doi.org\/10.1056\/nejmoa1915922","journal-title":"N Engl J Med"},{"key":"2313_CR46","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1016\/j.jcmg.2022.07.002","volume":"15","author":"RC Cury","year":"2022","unstructured":"Cury RC, Leipsic J, Abbara S et al (2022) CAD-RADS\u2122 2.0-2022 coronary artery disease-reporting and data system. JACC Cardiovasc Imaging 15:1974\u20132001. https:\/\/doi.org\/10.1016\/j.jcmg.2022.07.002","journal-title":"JACC Cardiovasc Imaging"},{"key":"2313_CR47","doi-asserted-by":"publisher","first-page":"e00","DOI":"10.1161\/CIR.0000000000001168","volume":"148","author":"SS Virani","year":"2023","unstructured":"Virani SS, Newby LK, Arnold SV et al (2023) 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines. Circulation 148:e00\u2013e00. https:\/\/doi.org\/10.1161\/CIR.0000000000001168","journal-title":"Circulation"},{"key":"2313_CR48","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.amjcard.2010.08.034","volume":"107","author":"N Ahmadi","year":"2011","unstructured":"Ahmadi N, Nabavi V, Hajsadeghi F, Flores F, French WJ, Mao SS, Shavelle D, Ebrahimi R, Budoff M (2011) Mortality incidence of patients with non-obstructive coronary artery disease diagnosed by computed tomography angiography. Am J Cardiol 107:10\u201316. https:\/\/doi.org\/10.1016\/j.amjcard.2010.08.034","journal-title":"Am J Cardiol"},{"key":"2313_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4870350","volume":"2019","author":"M Li","year":"2019","unstructured":"Li M, Wang X, Li X, Chen H, Hu Y, Zhang X, Tang X, Miao Y, Tian G, Shang H (2019) Statins for the primary prevention of coronary heart disease. Biomed Res Int 2019:4870350. https:\/\/doi.org\/10.1155\/2019\/4870350","journal-title":"Biomed Res Int"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-023-02313-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-023-02313-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T07:03:27Z","timestamp":1708499007000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-023-02313-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["2313"],"URL":"https:\/\/doi.org\/10.1007\/s00392-023-02313-1","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,4]]},"assertion":[{"value":"14 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors had no relationships with medical or pharmaceutical industries.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}